FI60567C - Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning - Google Patents

Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning Download PDF

Info

Publication number
FI60567C
FI60567C FI2099/73A FI209973A FI60567C FI 60567 C FI60567 C FI 60567C FI 2099/73 A FI2099/73 A FI 2099/73A FI 209973 A FI209973 A FI 209973A FI 60567 C FI60567 C FI 60567C
Authority
FI
Finland
Prior art keywords
gel
capa
fraction
process according
cancer
Prior art date
Application number
FI2099/73A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI60567B (fi
Inventor
Knut Bertil Bjoerklund
Original Assignee
Bonnierfoeretagen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonnierfoeretagen Ab filed Critical Bonnierfoeretagen Ab
Application granted granted Critical
Publication of FI60567B publication Critical patent/FI60567B/fi
Publication of FI60567C publication Critical patent/FI60567C/fi

Links

Classifications

    • G01N33/5758—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI2099/73A 1972-07-10 1973-06-29 Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning FI60567C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27027372A 1972-07-10 1972-07-10
US27027372 1972-07-10

Publications (2)

Publication Number Publication Date
FI60567B FI60567B (fi) 1981-10-30
FI60567C true FI60567C (fi) 1982-02-10

Family

ID=23030635

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2099/73A FI60567C (fi) 1972-07-10 1973-06-29 Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning

Country Status (22)

Country Link
JP (2) JPS5817168B2 (OSRAM)
AR (1) AR197243A1 (OSRAM)
AT (1) AT336780B (OSRAM)
BE (1) BE802126A (OSRAM)
BR (1) BR7305142D0 (OSRAM)
CA (1) CA1039650A (OSRAM)
CH (1) CH617853A5 (OSRAM)
DD (2) DD113918A5 (OSRAM)
DE (2) DE2333740C2 (OSRAM)
DK (1) DK139898B (OSRAM)
ES (1) ES416726A1 (OSRAM)
FI (1) FI60567C (OSRAM)
FR (1) FR2191885B1 (OSRAM)
GB (2) GB1443054A (OSRAM)
IL (1) IL42594A (OSRAM)
IN (1) IN138903B (OSRAM)
IT (1) IT1009527B (OSRAM)
NL (1) NL7309257A (OSRAM)
NO (1) NO146338C (OSRAM)
SE (3) SE440697B (OSRAM)
SU (1) SU581842A3 (OSRAM)
ZA (1) ZA734632B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS56145297A (en) * 1980-04-11 1981-11-11 Kureha Chem Ind Co Ltd Preparative method of glycoprotein having immunosupressing activity
GB2121417A (en) * 1982-02-22 1983-12-21 Carlton Med Prod Antigens and antibodies useful in the detection of cancer

Also Published As

Publication number Publication date
NO146338B (no) 1982-06-01
SE440597B (sv) 1985-08-12
GB1443053A (en) 1976-07-21
SE418186B (sv) 1981-05-11
SE440697B (sv) 1985-08-12
DE2333740A1 (de) 1974-01-31
FR2191885A1 (OSRAM) 1974-02-08
IL42594A (en) 1976-08-31
FR2191885B1 (OSRAM) 1977-07-01
IN138903B (OSRAM) 1976-04-10
SE7609837L (sv) 1976-09-06
IT1009527B (it) 1976-12-20
JPS5817168B2 (ja) 1983-04-05
SU581842A3 (ru) 1977-11-25
CA1039650A (en) 1978-10-03
JPS6018011B2 (ja) 1985-05-08
SE7609836L (sv) 1976-09-06
DK139898B (da) 1979-05-14
ATA600773A (de) 1976-09-15
IL42594A0 (en) 1973-08-29
AU5728673A (en) 1975-01-09
JPS56115954A (en) 1981-09-11
AT336780B (de) 1977-05-25
DD118946A5 (OSRAM) 1976-03-20
ES416726A1 (es) 1976-06-16
NO146338C (no) 1982-09-08
NL7309257A (OSRAM) 1974-01-14
AR197243A1 (es) 1974-03-22
BE802126A (fr) 1973-11-05
BR7305142D0 (pt) 1974-08-22
DD113918A5 (OSRAM) 1975-07-05
JPS4955823A (OSRAM) 1974-05-30
DE2333740C2 (de) 1987-01-22
DK139898C (OSRAM) 1979-10-08
FI60567B (fi) 1981-10-30
GB1443054A (en) 1976-07-21
ZA734632B (en) 1974-06-26
DE2366609C2 (OSRAM) 1988-02-25
CH617853A5 (en) 1980-06-30

Similar Documents

Publication Publication Date Title
US4160018A (en) Stabilized cancer associated polypeptide antigen and preparation thereof
Hajto et al. Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients
US3960827A (en) Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US5310653A (en) Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis
Kupchik et al. Carcinoembryonic antigen (s) in liver disease: II. Isolation from human cirrhotic liver and serum and from normal liver
Bhattacharya et al. Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor‐associated antigens
US4298590A (en) Detection of malignant tumor cells
Goldenberg et al. Antigens associated with normal and malignant gastrointestinal tissues
Ackerman et al. The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay.
US5866690A (en) Detection of malignant tumor cells
JPS6129464B2 (OSRAM)
US4486538A (en) Detection of malignant tumor cells
Imamura et al. Analysis of human ovarian tumor antigens using heterologous antisera: detection of new antigenic systems
Solomon Molecular heterogeneity of immunoglobulin-M (γM-globulin)
US4211766A (en) Cancer associated polypeptide antigen compositions
BJÖRKLUND et al. IMMUNO‐HISTOCHEMICAL LOCALIZATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) AND CARCINO‐EMBRYONIC ANTIGEN (CEA) IN BREAST CANCER: A Comparative Study
FI60567C (fi) Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning
Neville et al. Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma
Bjorklund et al. Localization of synthesis of TPA in normal and malignant human tissues by immunohistological techniques
JPS6259783B2 (OSRAM)
Halliday et al. Isoferritin composition of tissues and serum in human cancers
Harvey et al. Demonstration of two molecular variants of carcinoembryonic antigen by concanavalin A sepharose affinity chromatography
Dickinson et al. The chemical nature of cancer basic protein
McPherson et al. Carcinoembryonic antigen (CEA): Comparison of the farr and solid‐phase methods for detection of CEA
Knapp Partial Characterisation of an Oncofetal Pancreatic Antigen: Its Role in the Differential Diagnosis and Therapy of Patients with Pancreatic Cancer